JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Priest, R. M.
Right arrow Articles by Ward, J. P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Priest, R. M.
Right arrow Articles by Ward, J. P. T.

Vol. 285, Issue 3, 975-982, June 1998

Membrane Potential-Dependent and -Independent Vasodilation in Small Pulmonary Arteries from Chronically Hypoxic Rats1

Rachel M. Priest, Thomas P. Robertson, Richard M. Leach2 and Jeremy P. T. Ward

Department of Allergy and Respiratory Medicine, UMDS Smooth Muscle Group, UMDS, St Thomas' Campus, London SE1 7EH, United Kingdom


    Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References

Chronic hypoxia is associated with altered pulmonary vasoreactivity, and it has been suggested that an increased response to voltage-dependent vasodilators may relate to enhanced Ca++ entry via voltage-dependent channels, secondary to depolarization. Few studies have been performed on small pulmonary arteries, and it is unknown whether they are depolarized after chronic hypoxia. We examined the resting membrane potential, and the actions of voltage-dependent (verapamil, levcromakalim) and -independent (isoproterenol, forskolin, papaverine) vasodilators in small (~300 µm internal diameter) pulmonary arteries from chronically hypoxic rats. The resting membrane potential was more positive in arteries after chronic hypoxia (control: -60 ± 0.5 mV; hypoxic: -54.4 ± 1.1 mV; P < .01), and this was reflected by a shift to the left of the response curves for K+ and 4-aminopyridine. In arteries constricted with prostaglandin F2alpha the response to verapamil and levcromakalim was increased after chronic hypoxia, although maximum prostaglandin F2alpha -induced tension was unchanged, which implies a reduction in voltage-independent constrictor mechanisms. Although vasorelaxation to isoproterenol was depressed in arteries from hypoxic rats, forskolin-induced relaxation was enhanced substantially, and because the response to the phosphodiesterase inhibitor papaverine was unchanged, we suggest that this reflects an up-regulation of adenylate cyclase. In conclusion, chronic hypoxia resulted in a significant depolarization in small pulmonary arteries, but this may explain only partly the increased efficacy of voltage-dependent vasodilators. Whether the reduction in voltage-independent constrictor mechanisms is related to the apparent up-regulation of adenylate cyclase remains to be elucidated.


    Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References

Chronic hypoxic lung disease generally is associated with PHT and subsequent remodeling and altered vasoreactivity of the pulmonary vasculature. The precise nature of the changes in vasoreactivity, in particular those involving mechanisms that could potentially be targets for vasodilator therapy (Karamsetty et al., 1995), is still controversial. Two such systems that have a major influence on vasomotor tone are the activities of voltage-dependent ionic currents in the membrane and the intracellular nucleotides cAMP and cGMP.

Acute hypoxia inhibits a delayed rectifier K+ current and causes depolarization in the smooth muscle cells from the pulmonary artery (Post et al., 1992), and we have shown that chronic hypoxia results in a maintained reduction in delayed rectifier K+ current in cells from small pulmonary arteries of rats, even in normoxic conditions (Smirnov et al., 1994). This theoretically should result in depolarization of the intact artery, but Suzuki and Twarog (1982) have reported that although large pulmonary artery segments from chronic hypoxic rats were depolarized compared with controls, small pulmonary arteries were hyperpolarized (Suzuki and Twarog, 1982). In agonist-constricted large pulmonary arteries both blockers of voltage-dependent Ca++ channels or K+ channel openers have been more effective in hypoxia- and monocrotaline-induced PHT (Rodman, 1992; Wanstall and O'Donnell, 1992; Wanstall et al., 1994), and a study on small pulmonary arteries after monocrotaline-induced PHT also showed an enhanced response to pinacidil, a K+ channel opening agent (Wanstall et al., 1993). These reports would be consistent with an enhanced depolarization during agonist stimulation, and a subsequent increase in Ca++ entry via voltage-dependent Ca++ channels. However, they also could reflect a decrease in Ca++ release from intracellular stores, such that the proportion of the rise in cytosolic Ca++ caused by voltage-dependent Ca++ entry mechanisms was increased, as conjectured by Wanstall et al. (1994). Whereas enhanced depolarization alone might be expected to increase the rise in intracellular Ca++ and thus tension, a decreased release from Ca++ stores would do the reverse and reduce tension. It is interesting, therefore, that some reports have shown either no change or a reduction in agonist-induced tone of pulmonary arteries from animals with experimental PHT (Rodman, 1992; Rogers et al., 1992; Wanstall et al., 1995).

cAMP and cGMP influence vasomotor tone primarily via mechanisms involving intracellular Ca++ handling (Ushio-Fukai et al., 1993), although cGMP also has been reported to activate K+ channels (Hampl et al., 1995). The roles of NO and cGMP in PHT have been studied extensively, and several studies have shown a decreased potency of NO donors such as SNP (Crawley et al., 1992; Rodman, 1992; Wanstall et al., 1992). Conversely, few reports have been concerned with cAMP-dependent mechanisms during PHT. Isoproterenol-induced relaxation of the pulmonary vasculature may be either unchanged (Rodman, 1992; Russ and Walker, 1993) or reduced (Altiere et al., 1986; Shaul et al., 1990). It has been proposed that the latter is caused by a decrease in beta adrenoceptor density, because there was no change in adenylate cyclase activity (Shaul et al., 1990), and Rodman (1992) reported that dibutyryl-cAMP-induced relaxation was unchanged in large pulmonary arteries after chronic hypoxia.

Several aspects remain to be clarified. It is unclear whether the reduced outward current described for isolated cells from small pulmonary arteries of chronically hypoxic rats is of physiological significance in the intact artery, nor whether any depolarization is sufficient to explain the enhanced effects of voltage-dependent vasodilators such as verapamil and K+ channel openers, if the latter occurs in small arteries during chronic hypoxia. The role of cAMP, which may affect Ca++ handling, also has been largely overlooked. Changes in pulmonary vascular resistance primarily depend on the activity of small muscular pulmonary arteries, and we have shown that these small arteries differ from conduit arteries in their response to a variety of agents (Leach et al., 1992). However, the great majority of previous studies has been performed on large arteries. We therefore have examined whether chronic hypoxia results in a physiologically significant depolarization in small (~300 µm internal diameter) pulmonary arteries of the rat, and whether this is reflected in the actions of the voltage-dependent vasodilator verapamil and the K+ channel opener levcromakalim. We have studied further the response to agents that affect intracellular cAMP, including isoproterenol, forskolin and papaverine, and for comparison, we have re-examined the effects of the NO-donor SNP.

    Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References

Animals. Adult male Wistar rats (230-250 g initial weight) were maintained in a normobaric environmental chamber breathing either air (control group) or 10% O2 (balance N2) (chronic hypoxic group, CH). O2 was monitored continuously (Servomex OA 580 analyzer, Servomex Ltd., Sussex, UK), and CO2 was maintained at less than 0.2% by use of soda-lime scrubbers. A 12-hr light-dark cycle was imposed and the temperature controlled at 22 ± 1°C. After 28 days animals were removed from the chamber, weighed, anesthetized with ether and sacrificed by cervical dislocation. The lungs and a section of small bowel were excised quickly and placed in a PSS containing (in mM): NaCl, 118; NaHCO3, 24; MgSO4, 1; NaH2PO4, 0.435; glucose, 5.56; Na-pyruvate, 5; CaCl2, 1.8; and KCl, 4, equilibrated with 5% CO2 in O2 (pH 7.35-7.40). One group of 16 control and 16 CH rats were used for estimation of hematocrit, right ventricular and heart weight and arterial blood PO2. Arterial blood was taken from anesthetized rats breathing room air or 10% O2 as appropriate. All animals received humane care in compliance with the Home Office (UK) "Guidance on the operation of the Animals (Scientific Procedures) Act" published by Her Majesty's Stationery Office.

Tissue preparation. Small intrapulmonary arteries (control: 331 ± 15 µm, n = 66; CH: 311 ± 18 µm, n = 57) or small mesenteric arteries (control: 276 ± 19 µm, n = 29; CH: 238 ± 11 µm, n = 25) were dissected free of connective tissue and mounted in a small vessel myograph as described previously (Leach et al., 1992) and equilibrated with 5% CO2 in O2 (pH 7.35-7.40, 37°C). Both control and CH pulmonary arteries were stretched to give an equivalent transmural pressure of 30 mm Hg, at which both were at the peak of the length-tension curve (Leach et al., 1991, 1992). The presence of a functioning endothelium was determined by application of ACh (10 µM) after agonist-induced contraction. After 60 min equilibration the arteries were subjected to a standard run-up procedure of three 4-min exposures to PSS containing high K+ (KPSS, 75 mM [K+], equimolar substitution for NaCl) (Leach et al., 1992).

Resting membrane potential measurement. RMP was determined in small pulmonary arteries mounted on a myograph and stretched and equilibrated as above. Conventional KCl-filled borosilicate glass microelectrodes of ~60 megohm resistance were advanced into the vessel wall with a micromanipulator. RMP was measured with an opto-isolated high-impedance headstage coupled to a standard microelectrode amplifier (Neurolog, Digitimer Ltd, Crawley, UK). The results obtained from between 5 and 17 impalements were averaged for each preparation. Each electrode rarely was used for more than one impalement, and the voltage was corrected for tip potential for each electrode and impalement.

Experimental protocols. Chronic hypoxia has been associated with a decrease in voltage-gated K+ current density in single smooth muscle cells from pulmonary artery, and as a result a more positive RMP estimated by current-clamp (Smirnov et al., 1994). To ascertain whether the data from single cells were reflected by functional changes in the intact artery, the effects of chronic hypoxia on RMP, K+ depolarization and the response to K+ channel blockers were examined in small pulmonary arteries. RMP was estimated in arteries from control and CH rats as described above. However, it was impossible to obtain good impalements and meaningful estimations of membrane potential during agonist stimulation in these small arteries. The concentration-tension relationship for K+-depolarization was examined in control and CH arteries by replacing the bath solution at 5-min intervals with PSS containing increasing concentrations (20-90 mM) of KCl, iso-osmolar substitution for NaCl. Concentration-response relationships were constructed for TEA (large conductance Ca++-sensitive K+ channels), 4-AP (delayed rectifier) and apamin (small conductance Ca++-sensitive K+ channels) in arteries from control and CH rats.

Cumulative concentration-response relationships were determined after stable precontraction with 50 µM PGF2alpha (EC80) for verapamil and levcromakalim, which act via ion channels and therefore are influenced by the membrane potential; isoproterenol, forskolin and papaverine, which increase cAMP by membrane receptors, direct activation of adenylate cyclase and inhibition of phosphodiesterases, respectively; and the NO-donor SNP. In some experiments with verapamil Ni (1 mM) was added after the final addition to establish the requirement of verapamil-insensitive tone for Ca++ entry. Blockers of voltage-activated Ca++ channels, K+ channel openers and NO were proposed variously as potential vasodilators for PHT, and the relative efficacy of verapamil, levcromakalim and SNP therefore also were examined in systemic (mesenteric) arteries. The role of NO in the vasorelaxation induced by isoproterenol and forskolin was investigated after preincubation for 20 min with L-NMMA (100 µM). The effect of L-NMMA on basal tone also was determined. Drugs were prepared as stock solutions each day and added directly to the bath. Tension was allowed to stabilize after every addition and is expressed in terms of the initial PGF2alpha -induced tension.

Chemicals and solutions. All drugs were obtained from Sigma (Poole, UK), with the exception of PGF2alpha (Upjohn Pharmaceuticals Ltd., Crawley, UK) and L-NMMA (Novabiocem, Nottinghamshire, UK). Other chemicals were of analytical quality (BDH, Southampton, UK). All drugs were prepared as stock solutions with use of PSS, and for 4-AP the pH was corrected to 7.4 by addition of HCl acid. PSS was made up for each experiment with water freshly drawn from a reverse osmosis-deionization plant with UV irradiation (Elgastat, Elga Ltd, Welwyn Garden City, UK).

Data and statistical analysis. Absolute developed tension is given as mN mm-1 artery length, or as % of tension developed to KPSS (Leach et al., 1992). For vasorelaxation experiments tensions are expressed as percent of the initial tension. The EC50 and maximum response were estimated for individual concentration-response curves by nonlinear least-squares regression (SigmaStat, SPSS Scientific GmbH, Erkrath, Germany) where appropriate. EC50 values were converted to negative logarithmic values for all statistical analysis, although for ease of comprehension EC50 values [±95% confidence limits] are given in the text. All other values are given as mean ± S.E. Data were compared using an unpaired Student's t-test or ANOVA as appropriate (SigmaStat, SPSS Scientific GmbH). Differences were considered significant at P < .05.

    Results
Top
Abstract
Introduction
Methods
Results
Discussion
References

Body weight, RV/LV ratio, hematocrit and PaO2. Both body weight and PaO2 were reduced significantly in the CH rats compared with the controls, whereas the RV/LV ratio, the RV body weight ratio and hematocrit were increased significantly, consistent with the development of chronic hypoxemia and concomitant pulmonary hypertension (table 1).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Comparison of experimental groups

Pulmonary artery function. The tension developed in small pulmonary arteries from control and CH rats in response to KPSS or PGF2alpha (50 µM) is shown in figure 1. Arteries from CH rats did not develop a significantly greater tension than control arteries for either agent. Preincubation with L-NMMA (100 µM) did not significantly increase PGF2alpha -induced tension in arteries from either the control or CH group. L-NMMA, however, did cause a small but significant increase in basal (unstimulated) tone in arteries from both control (0.03 ± 0.01 mN·mm-1, n = 11, P < .05) and CH rats (0.07 ± 0.03 mN·mm-1, n = 10, P < .05), which suggests that basal release of NO was unimpaired.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   KPSS and PGF2alpha (50 µM) induced tension development in small pulmonary arteries from control (square ) and CH (black-square) rats. There was no significant difference between control and CH groups (KPSS: control n = 41, CH n = 36; PGF2alpha : control n = 30, CH n = 33). L-NMMA (100 µM) did not cause a significant increase in PGF2alpha -induced tension in either group (Control n = 10; CH n = 8).

RMP, K+ depolarization and K+ channel blockade. The RMP in small pulmonary endothelium-intact arteries from CH rats was stable, and significantly more positive than in those from control rats (Control: -60.2 ± 0.5 mV, n = 5; CH: -54.4 ± 1.1 mV, n = 5; P < .01). This was reflected by a significant shift to the left in the K+ depolarization concentration-response curve (fig. 2), such that the EC50 for K+ was reduced from 41.9 [-1.11,+1.14] mM (n = 7) in controls to 31.4 [-2.61,+2.85] mM in CH rats (n = 8, P < .01). The maximum tension extrapolated from the least-squares fit was increased in arteries from CH rats compared with those from control rats, but this did not reach significance (Control: 2.36 ± 0.13 mN·mm-1, n = 7; CH: 2.58 ± 0.19 mN·mm-1, n = 8; NS). TEA (to 30 mM) and apamin (to 10 µM) had no effect on pulmonary artery tension, suggesting that neither large nor small conductance Ca++-sensitive K+ channels play a significant role in the maintenance of RMP in this tissue. 4-AP however caused a concentration-dependent increase in tension greater than 1 mM in arteries from controls (fig. 3), reaching a tension of 10.5 ± 1.2% KPSS at 10 mM (n = 6). This would be consistent with a delayed rectifier K+ current having a major role in the modulation of RMP. In pulmonary arteries from CH rats the 4-AP concentration-response curve was shifted substantially to the left, such that significant tension was developed at 100 µM 4-AP, and at 3 mM 4-AP tension had increased to 41.4 ± 5.8% KPSS (n = 7) (fig. 3). At 10 mM the preparations from CH rats became oscillatory, and measurements could not be made.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 2.   Tension development in small pulmonary arteries from control (open circle , n = 7) and CH (bullet , n = 8) rats to increasing depolarization with K+ (iso-osmolar substitution for Na+). Symbols are mean ± S.E. * denotes P < .05 at that concentration between control and CH arteries.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of increasing concentrations of 4-AP on tension in small pulmonary arteries from control (open circle , n = 6) and CH (bullet , n = 7) rats, and in arteries from control rats in the presence of 30 mM K+ (black-square, n = 7). Tension is expressed in terms of that to KPSS, and symbols are mean ± S.E. Where symbols have no error bar the S.E. is smaller than the symbol. * denotes P < .05 at that concentration compared with control for each group.

Effect of chronic hypoxia on the actions of vasodilators. Verapamil caused a concentration-dependent relaxation of arteries from control rats with a significantly smaller maximum relaxation in small pulmonary arteries (46.3 ± 6.1% initial tone, n = 6) than in small mesenteric arteries (93.9 ± 2.1%, n = 6, P < .001), and a significantly greater EC50 (Pulmonary: 80 [-22,+30] nM; mesenteric: EC50: 26 [-7,+10] nM, P < .001) (fig. 4). In pulmonary arteries from CH rats the maximum relaxation was significantly greater than in controls (66.8 ± 4.9%, n = 5, P < .05), and the curve was shifted to the left (EC50: 30 [-11,+18] nM, P < .01). There was no significant difference in either maximum relaxation or EC50 in mesenteric arteries from CH rats (87.9 ± 1.9%, EC50: 19 [-6,+8] nM, n = 5) (fig. 4).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   Verapamil concentration-response curves for small pulmonary arteries from control (open circle , n = 6) and CH (bullet , n = 5) rats, and small mesenteric arteries from control (square , n = 6) and CH (black-square, n = 5) rats. Symbols are mean ± S.E. Where symbols have no error bar the error is smaller than the symbol. * denotes P < .05 at that concentration between control and CH pulmonary arteries.

Relaxation to levcromakalim showed a profile similar to verapamil, with a maximum relaxation in pulmonary arteries from controls of 45.1 ± 5.5% (EC50: 528 [-218,+371] nM, n = 7). The maximum relaxation to levcromakalim was again significantly greater in mesenteric arteries (102.5 ± 4.5%, n = 8, P < .001) than in pulmonary arteries, and the curve was shifted to the left (EC50: 216 [-62,+86] nM, P < .05) (fig. 5). As with verapamil, the maximum relaxation to levcromakalim in pulmonary arteries from CH rats was significantly greater than control (60.5 ± 3.0, n = 6, P < .05), and the curve was shifted to the left (EC50:182 [-36,+44] nM, P < .01). There was again no significant difference in either maximum relaxation or EC50 in mesenteric arteries from CH rats (97.9 ± 5.6%, EC50: 195 [-85,+149] nM, n = 6) (fig. 5).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 5.   Levcromakalim concentration-response curves for small pulmonary arteries from control (open circle , n = 7) and CH (bullet , n = 6) rats, and small mesenteric arteries from control (square , n = 8) and CH (black-square, n = 6) rats. Symbols are mean ± S.E. Where symbols have no error bar the error is smaller than the symbol. * denotes P < .05 at that concentration between control and CH pulmonary arteries.

SNP did not cause complete relaxation of PGF2alpha -induced tone in small pulmonary arteries, and maximum relaxation was not changed after chronic hypoxia (Control: 64.1 ± 5.0%, n = 10; CH: 62.1 ± 3.3%, n = 8; NS). There was however a small but significant shift to the right of the concentration-response curve (EC50: Control: 7.8 [-3.3,+5.9] nM, n = 10; CH: 37.2 [-13.4,+20.8] nM, n = 8; P < .001) (fig. 6). SNP relaxed mesenteric arteries from controls to a much greater extent than pulmonary arteries, although there was no difference in the EC50 (Control mesenteric: 86.4 ± 3.6%, P < .01; EC50: 5.1 [-1.8,+2.7] nM, NS; n = 9). Mesenteric arteries from CH rats were not significantly different from controls (CH mesenteric: 90.5 ± 2.9, NS; EC50: 4.4 [-1.6,+2.4] nM, NS; n = 8) (fig. 6).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   SNP concentration-response curves for small pulmonary arteries from control (open circle , n = 10) and CH (bullet , n = 8) rats, and small mesenteric arteries from control (square , n = 9) and CH (black-square, n = 8) rats. Symbols are mean ± S.E. Although there was no significant difference between individual means, the EC50 was increased significantly in CH rats (see text).

Forskolin is a direct activator of adenylate cyclase, but forskolin-dependent relaxation in pulmonary arteries recently was reported to have an NO-dependent component (Priest et al., 1997). Therefore, experiments also were performed in the presence of L-NMMA. In pulmonary arteries from control rats forskolin induced a maximum relaxation extrapolated from the least-squares fit of 56.2 ± 5.3% initial tone, with an EC50 of 436 [-175,+298] nM (n = 5) (fig. 7). In the presence of L-NMMA (100 µM) the maximum relaxation was not altered significantly (50.0 ± 5.3%, n = 6; NS), whereas the EC50 was significantly increased (EC50: 1140 [-470,+799] nM, n = 6; P < .05). In pulmonary arteries from CH rats, however, the maximum relaxation to forskolin was increased significantly to 96.7 ± 3.4%, n = 5; P < .001), although the EC50 was unchanged (362 [-83,+107] nM, n = 5; NS). In the presence of L-NMMA the EC50 for forskolin in arteries from CH rats again was increased (2167 [-425,+528] nM, n = 4; P < .01) (fig. 7). There was no significant difference between the EC50 for forskolin in the presence of L-NMMA for control and CH rats, which suggests that the NO-dependent component of forskolin-induced relaxation was unchanged after chronic hypoxia. Because dibutyryl-cAMP-induced relaxation previously was stated to be unaltered in large CH rats (Rodman, 1992), experiments also were performed for forskolin alone in large pulmonary arteries (~1.5 mm internal diameter) from control and CH rats. In these large arteries maximum relaxation to forskolin was greater than in small control arteries, but was unchanged after chronic hypoxia (Control: 93 ± 6%, n = 6; CH: 105 ± 12%, n = 4; NS). However in direct contrast to the small arteries, the potency for forskolin in large pulmonary arteries was reduced significantly after chronic hypoxia (EC50: Control: 300 [-70,+93] nM; CH: 848 [-419,+827] nM; P < .01).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 7.   Forskolin concentration-response curves for small pulmonary arteries from control (open circle , n = 5) and CH (bullet , n = 6) rats, and in the presence of 100 µM L-NMMA (control: square , n = 5; CH: black-square, n = 4). Symbols are mean ± S.E. Where symbols have no error bar the error is smaller than the symbol. * denotes P < .05 at that concentration between control and CH arteries in the absence of L-NMMA; dagger  denotes P < .05 between control and CH arteries in the presence of L-NMMA.

Isoproterenol is understood classically to induce relaxation by an increase in cAMP, although we recently also found a significant NO-dependent component in pulmonary arteries of the rat (Priest et al., 1997). Figure 8 shows isoproterenol-induced relaxation in small pulmonary arteries and in the presence of L-NMMA. It was not possible to fit the response curves adequately for isoproterenol, but differences are clearly apparent in the figure. In pulmonary arteries from CH rats relaxation to isoproterenol was reduced substantially compared with controls, and there was a highly significant difference at each individual concentration of isoproterenol (Control: n = 6; CH: n = 6; P < .01). L-NMMA substantially reduced relaxation to isoproterenol in control arteries at all concentrations (Control L-NMMA: n = 5; P < .01), but effectively abolished relaxation in CH arteries (CH + L-NMMA: n = 4).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 8.   Isoproterenol concentration-response curves for small pulmonary arteries from control (open circle , n = 6) and CH (bullet , n = 6) rats, and in the presence of 100 µM L-NMMA (control: square , n = 5; CH: black-square, n = 4). Symbols are mean ± S.E. Where symbols have no error bar the error is smaller than the symbol. * denotes P < .05 at that concentration between control and CH arteries in the absence of L-NMMA; dagger  denotes P < .05 between control and CH arteries in the presence of L-NMMA.

Papaverine induced relaxation of PGF2alpha -induced tone to below the base line in arteries from both control (110.8 ± 3.0%, n = 6) and CH rats (117.1 ± 4.7%, n = 7), and there was no significant difference between these values. There was, however, a small but significant reduction in EC50 for arteries from CH rats compared with control (Control: 5.5 [-1.3,+1.7] µM; CH: 3.6 [-0.7,+0.9] µM; P < .05) (fig. 9). Because papaverine also was reported to affect voltage-activated Ca++ channels, additional experiments were performed in the presence of 10 µM verapamil. Under these conditions there was no significant difference in EC50 between arteries from control and CH rats (Control: 4.5 [-0.4,+0.5] µM, n = 7; CH: 5.3 [-1.2,+1.6] µM, n = 5; NS).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 9.   Papaverine concentration-response curves for small pulmonary arteries from control (open circle , n = 6) and CH (bullet , n = 7) rats. * denotes P < .05 at that concentration between control and CH arteries. Symbols are mean ± S.E.

    Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References

PHT induced by chronic hypoxia is associated with vascular remodeling and muscularization of small pulmonary arteries. Although there was significant polycythemia and right ventricular hypertrophy in the CH group (table 1), which suggests the presence of PHT, there was no significant increase in maximum force development to either PGF2alpha or KPSS (fig. 1). A similar lack of increase in agonist-induced tone was reported in small pulmonary arteries from CH rats (Rogers et al., 1992), whereas in large pulmonary arteries at least two reports showed a reduction in force development, even though muscle mass was increased (Rodman, 1992; Wanstall et al., 1995). It is unclear whether this reflects a change in the ability of the smooth muscle to generate force, although it is unlikely to be related to an increase in basal tone as suggested by Wanstall et al. (1995), because maximum relaxation to papaverine did not differ between the two groups (fig. 9).

The RMP in small pulmonary arteries from CH rats was significantly more positive than in controls, consistent with our previous finding in isolated cells (Smirnov et al., 1994). This is in direct contrast to the results of Suzuki and Twarog (1982), who showed an hyperpolarization in small pulmonary arteries after chronic hypoxia. A depolarization from -60 to -54 mV as reported here for arteries from CH rats would be unlikely to have a very significant effect on voltage-activated Ca++ channels, and it is notable that there was no increase in basal tone (see above). It was therefore important to establish whether this relatively small depolarization was of any functional significance.

We examined the response to depolarization with K+ and found that the curve was shifted significantly to the left, as would be expected if there was a pre-existing and functionally significant depolarization (fig. 2), although maximum force was not altered. This is consistent with a previous report on small arteries from CH rats (Rogers et al., 1992). Because neither TEA nor apamin had any effect on resting tone, it can be assumed that neither large nor small conductance Ca++-activated K+ channels play a role in maintenance of the RMP, which is consistent with previous patch-clamp studies (Smirnov et al., 1994; Turner and Kozlowski, 1997). However, 4-AP, a relatively selective blocker of the delayed rectifier, did cause vasoconstriction, which suggests that this current is the major determinant of the RMP in this tissue, as proposed previously (Smirnov et al., 1994; Turner and Kozlowski, 1997). In arteries from CH rats the 4-AP response curve was shifted to the left (fig. 3). This is also consistent with a pre-existing depolarization, as the delayed rectifier is voltage activated.

Many agonists cause depolarization in addition to release of intracellular Ca++ stores and/or Ca++ entry via receptor-operated channels. If the cell was already slightly depolarized the total depolarization in the presence of such an agonist might be expected to be enhanced, leading to increased activity of voltage-activated Ca++ channels. Agonist-induced tension therefore might be more sensitive to blockers of these channels, or agents that cause hyperpolarization (Rodman, 1992). As previously shown for nifedipine in rat large pulmonary arteries (Rodman, 1992), verapamil caused a greater maximum relaxation, and the EC50 was smaller in small pulmonary arteries from CH compared with control rats (fig. 4). A similar response was observed for the K+ channel opener levcromakalim, again consistent with previous reports in large arteries for levcromakalim (Rodman, 1992) and pinacidil, although for the latter no increase in potency was observed in PGF2alpha -constricted arteries (Wanstall and O'Donnell, 1992; Wanstall et al., 1994). The possibility that PGF2alpha itself causes a greater depolarization in arteries from CH rats cannot be ruled out, however.

The maximum relaxation to verapamil and levcromakalim in small arteries from both groups was substantially less than that previously reported for similar agents in large arteries (Rodman, 1992; Wanstall and O'Donnell, 1992; Wanstall et al., 1994), and even in CH rats it only approached 60 to 70% of initial tone (figs. 4 and 5). In comparison there was almost complete relaxation to both verapamil and levcromakalim in mesenteric arteries, which were not affected by chronic hypoxia. This implies that unlike mesenteric and large pulmonary arteries, PGF2alpha -induced constriction in small pulmonary arteries depends only partially on Ca++ entry via voltage-activated Ca++ channels, although the fact that Ni abolished the remaining tone suggests that Ca++ entry via other routes is required. Because total PGF2alpha -induced tension was not increased in arteries from CH rats compared with controls, our results imply that other mechanisms may be decreased proportionately after chronic hypoxia, which suggests an alteration in Ca++ handling. A similar proposal was made by Wanstall et al. (1994) for constriction of large pulmonary arteries from CH rats by ET-1 and noradrenaline, although not PGF2alpha .

As previously reported for large pulmonary arteries from CH rats (Crawley et al., 1992; Rodman, 1992; Wanstall et al., 1992), and small arteries from monocrotaline-treated rats (Wanstall et al., 1993), the potency of SNP was reduced in small arteries from CH rats compared with controls, and there was no change in maximum relaxation. However, SNP only induced a maximum relaxation of ~64% of initial tone in our small pulmonary arteries compared with nearly complete inhibition of tone at maximally effective concentrations in large pulmonary arteries (Rodman, 1992; Wanstall et al., 1992), small pulmonary arteries from monocrotaline-treated rats (Wanstall et al., 1993) and the mesenteric arteries in this study (fig. 6). The relatively small (~4-fold) decrease in potency coupled with the lack of change in maximum relaxation in these small arteries, which contribute the major component of the increased pulmonary vascular resistance in PHT, may explain why the response to SNP in perfused lungs has been reported to be unchanged in CH rats (Adnot et al., 1991; Russ and Walker, 1993).

The greater maximum relaxation, and similar or greater potency for verapamil, levcromakalim and SNP in mesenteric arteries compared with small pulmonary arteries suggests that all these agents are essentially selective for the systemic circulation, even after chronic hypoxia, and that they would therefore be poor drugs for treating PHT. The greater maximum relaxation to SNP and pinacidil, and the significant increase in basal tone in small pulmonary arteries reported for monocrotaline-treated rats also suggests that the monocrotaline model of PHT may cause a more profound lesion in these small arteries than chronic hypoxia.

The experiments with forskolin, isoproterenol and papaverine were designed to investigate cAMP-mediated relaxation after chronic hypoxia. Isoproterenol is described classically as a cAMP-dependent vasorelaxant, acting via beta adrenoceptors to stimulate adenylate cyclase, and the response to isoproterenol has been reported to be depressed (Altiere et al., 1986; Shaul et al., 1990; Shaul et al., 1991) or unaffected (Rodman, 1992; Russ and Walker, 1993) in experimental PHT. Our results suggest that isoproterenol-induced relaxation is impaired substantially in small pulmonary arteries from CH rats (fig. 8), although there was also a significant proportion of the response that was sensitive to L-NMMA, and presumably therefore involved NO. The NO-dependent part of the response to isoproterenol was reduced only partly in arteries from CH rats, whereas in the presence of L-NMMA relaxation to isoproterenol in CH arteries, it was effectively abolished.

The results for isoproterenol contrast strongly to those for forskolin, a direct activator of adenylate cyclase, where the response was enhanced greatly in small arteries from CH rats (fig. 7). As we described previously (Priest et al., 1997), there was a component of forskolin-induced relaxation that was NO-dependent, but this was relatively unchanged in arteries from CH rats. The increased response to forskolin would be consistent with either an up-regulation of the adenylate cyclase, a down-regulation of phosphodiesterase activity or an increased sensitivity to intracellular cAMP. The increase in response to forskolin coupled with the decrease in the response to isoproterenol also suggests a defect in receptor-coupling, and indeed beta adrenoceptor density was reported to be decreased in large pulmonary arteries after chronic hypoxia (Shaul et al., 1990). However, the same report showed no change in the response to forskolin or in basal activity of adenylate cyclase in pulmonary arteries (Shaul et al., 1990). Rodman (1992) also reported that direct relaxation with dibutyryl-cAMP was unchanged in large pulmonary arteries from CH rats. Because this could represent a real difference between large and small pulmonary arteries, we re-examined the effects of forskolin in large arteries. In contrast to its effect on small arteries, forskolin could cause complete inhibition of induced tone in large arteries from controls. In large arteries from CH rats the maximum relaxation was unchanged, although there was a small (~2.5-fold) reduction in potency. Therefore, after chronic hypoxia small pulmonary arteries apparently behave differently to large pulmonary arteries in terms of adenylate cyclase and/or cAMP, which may have implications for the control of pulmonary vascular resistance in PHT.

Papaverine is a phosphodiesterase inhibitor that primarily causes relaxation by reducing the breakdown of cAMP (Holzmann et al., 1977). It was the only vasorelaxant used in this study that caused complete relaxation of PGF2alpha -induced tension in small pulmonary arteries, and in fact elicited more than 100% relaxation in both control and CH preparations, which indicates that small pulmonary arteries have some degree of intrinsic basal tone, although this was not increased in arteries from CH rats. There was a small increase in potency between control and CH arteries. Papaverine also may cause nonselective inhibition of voltage-activated Ca++ channels (Iguchi et al., 1992), and the increased potency in CH preparations therefore could reflect the more positive RMP. In the presence of verapamil, papaverine no longer showed any difference in potency between arteries from control and CH rats, which is entirely consistent with the latter hypothesis. The lack of effect of chronic hypoxia on the voltage-independent component of relaxation to papaverine might argue against any alterations in either phosphodiesterase activity or sensitivity to cAMP after chronic hypoxia, and in combination with the forskolin data provides further evidence for up-regulation of the adenylate cyclase.

It has been suggested that acute HPV is caused by inhibition of a K+ current, which results in depolarization and increased Ca++ entry (Post et al., 1992). A pre-existing depolarization therefore might be expected to enhance HPV, and in tissue from normal rats this is indeed the case, both in terms of the contractile response and the hypoxia-induced depolarization (Leach et al., 1994; Turner and Kozlowski, 1997). However, although we demonstrate here that pulmonary arteries from CH rats are depolarized, it has long been established that chronic hypoxia decreases the pressor response to acute hypoxia (McMurtry et al., 1978). We previously proposed that HPV depends on mechanisms in addition to depolarization alone, including Ca++ release from stores (Ward and Robertson, 1995). The decrease in HPV after chronic hypoxia may therefore be related partly to the putative changes in Ca++ handling that are discussed above.

In conclusion, we have demonstrated a small but physiologically significant depolarization in small pulmonary arteries from CH rats, in direct contrast to the report of Suzuki and Twarog (1982); and although this depolarization (or the underlying decrease in outward current) potentiated the effects of further depolarization by K+ or channel blockade with 4-AP, it was insufficient to cause any noticeable increase in basal tone. The increased efficacy of the voltage-dependent vasodilators verapamil and levcromakalim was similar to that previously reported for large arteries and would be consistent with an enhanced depolarization during agonist stimulation, as suggested by Rodman (1992). However, in comparison with other studies our results imply that the increase in cytosolic Ca++ in small pulmonary arteries depends less on voltage-dependent Ca++ entry than in large pulmonary arteries or systemic arteries, and there is circumstantial evidence that the voltage-independent component, that is release from stores or entry through voltage-independent channels, is reduced after chronic hypoxia. It is currently unclear whether this could be related to the apparent up-regulation of the adenylate cyclase in small arteries, and further studies on the function of intracellular Ca++ stores, direct measurement of adenylate cyclase activity and intracellular cAMP during chronic hypoxia are required.

    Acknowledgments

We thank David Hucks for his technical assistance with some of this work.

    Footnotes

Accepted for publication February 4, 1998.

Received for publication September 23, 1997.

1 Supported by the British Heart Foundation and the Wellcome Trust (grants 038048 and 043357).

2 Present address: Department of Intensive Care, St Thomas' Hospital, London SE1 7EH, UK.

Send reprint requests to: Dr. J.P.T. Ward, Department of Medicine, UMDS, St Thomas' Campus, Lambeth Palace Road, London SE1 7EH, UK.

    Abbreviations

4-AP, 4-aminopyridine; ACh, acetylcholine; cAMP, cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate; CH, chronic hypoxic group; HPV, hypoxic pulmonary vasoconstriction; KPSS, physiological salt solution containing 75 mM [K+], equimolar substitution for NaCl; L-NMMA, NG-monomethyl-L-arginine; NO, nitric oxide; PGF2alpha , prostaglandin F2alpha ; PHT, pulmonary hypertension; PSS, physiological salt solution; RMP, resting membrane potential; RV, right ventricle; SNP, sodium nitroprusside; TEA, tetraethylammonium.

    References
Top
Abstract
Introduction
Methods
Results
Discussion
References


0022-3565/98/2853-0975$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. R. S. Broughton, B. R. Walker, and T. C. Resta
Chronic hypoxia induces Rho kinase-dependent myogenic tone in small pulmonary arteries
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L797 - L806.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Leblais, E. Delannoy, F. Fresquet, H. Begueret, N. Bellance, S. Banquet, C. Allieres, L. Leroux, C. Desgranges, A. Gadeau, et al.
{beta}-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent {beta}2 component in pulmonary hypertension
Cardiovasc Res, January 1, 2008; 77(1): 202 - 210.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. D. Fike, M. R. Kaplowitz, Y. Zhang, and J. A. Madden
Voltage-gated K+ channels at an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets
Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1169 - L1176.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Vankova, V. A. Snetkov, G. A. Knock, P. I. Aaronson, and J. P.T. Ward
Euhydric hypercapnia increases vasoreactivity of rat pulmonary arteries via HCO3- transport and depolarisation
Cardiovasc Res, February 1, 2005; 65(2): 505 - 512.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. B. Schindler, A. A. Hislop, and S. G. Haworth
Postnatal Changes in Response to Norepinephrine in the Normal and Pulmonary Hypertensive Lung
Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 641 - 646.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Bonnet, J.-P. Savineau, W. Barillot, E. Dubuis, C. Vandier, and P. Bonnet
Role of Ca2+-sensitive K+ channels in the remission phase of pulmonary hypertension in chronic obstructive pulmonary diseases
Cardiovasc Res, November 1, 2003; 60(2): 326 - 336.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Bonnet, E. Dubuis, C. Vandier, S. Martin, R. Marthan, and J.-P. Savineau
Reversal of chronic hypoxia-induced alterations in pulmonary artery smooth muscle electromechanical coupling upon air breathing
Cardiovasc Res, March 1, 2002; 53(4): 1019 - 1028.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. A. Coppock, J. R. Martens, and M. M. Tamkun
Molecular basis of hypoxia-induced pulmonary vasoconstriction: role of voltage-gated K+ channels
Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L1 - L12.
[Abstract] [Full Text] [PDF]